Copyright
©The Author(s) 2016.
World J Methodol. Mar 26, 2016; 6(1): 56-64
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.56
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.56
MND subtype | Clinical features | Possible differential diagnoses |
ALS | Affect both upper MNs and lower MNs | Cervical myeloneuropathy |
Onset 50 or 60 s | HIV | |
Median survival 3 to 5 yr | ||
PLS | Only affect upper MNs 3 yr from onset | Cervical myelopathy |
Onset 50 s | Nutritional (B12 or Cu deficiency) | |
Profound spasticity | Primary progressive multiple sclerosis | |
Progressive quadriparesis | Hereditary spastic paraparesis | |
Late cranial nerve involvement | Stiff person syndrome | |
Rarely bulbar onset | Tropical spastic paraparesis (HTLV1) | |
Slow progression | Adrenomyeloneuropathy | |
Median survival 5 to 10 yr | Hexosaminidase A deficiency | |
Corticobasal degeneration | ||
PMA | Only affect upper MNs 3 yr from onset | Benign fasciculations |
Focal asymmetric distal weakness, followed by proximal involvement | Post-polio syndrome | |
Late bullar/respiratory involvement | Adult onset spinal muscular atrophy | |
Earlier onset than ALS | Inclusion body myositis | |
Raised CK (< 10 × normal) | ||
Median survival 3 to 5 yr |
- Citation: Balendra R, Patani R. Quo vadis motor neuron disease? World J Methodol 2016; 6(1): 56-64
- URL: https://www.wjgnet.com/2222-0682/full/v6/i1/56.htm
- DOI: https://dx.doi.org/10.5662/wjm.v6.i1.56